Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
13,207
Total Claims
$887K
Drug Cost
657
Beneficiaries
$1,349
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 1,825 Geriatric Medicine providers
-48%
Opioid rate vs peers
1.3% vs 2.6% avg
+9%
Cost per patient vs peers
$1,349 vs $1,237 avg
+40%
Brand preference vs peers
12.8% vs 9.2% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
1.3%
Opioid Rate
175
Opioid Claims
$2,660
Opioid Cost
11.4%
Long-Acting Rate
Brand vs Generic
Brand: 1,683 claims · $635K
Generic: 11,445 claims · $247K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 349 | $164K |
| Rivaroxaban | 136 | $53K |
| Sitagliptin Phosphate | 45 | $30K |
| Insulin Glargine,hum.Rec.Anlog | 108 | $26K |
| Fluticasone/Vilanterol | 70 | $25K |
| Sitagliptin Phos/Metformin Hcl | 24 | $21K |
| Empagliflozin | 36 | $18K |
| Linagliptin | 52 | $16K |
| Mirabegron | 12 | $15K |
| Fluticasone/Umeclidin/Vilanter | 21 | $14K |
| Sacubitril/Valsartan | 17 | $11K |
| Insulin Lispro | 30 | $11K |
| Insulin Aspart | 26 | $10K |
| Divalproex Sodium | 168 | $9,693 |
| Epoetin Alfa | 19 | $9,454 |
Prescribing Profile
Patient Profile
82
Avg Age
65%
Female
2.15
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About